Orion director granted 19,150 restricted shares

Hoogerbrugge Jacqueline reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hoogerbrugge Jacqueline reported acquisition or exercise transactions in this Form 4 filing.

Orion S.A. director Jacqueline Hoogerbrugge received an equity compensation grant of 19,150 restricted common shares on June 26, 2026. The grant was made at no cash cost per share and increased her direct holdings to 32,085 common shares.

The restricted shares will vest on the day prior to Orion S.A.'s 2027 Annual General Meeting of Shareholders, meaning she must remain in service through that date to fully earn the award.

Insider Trade Summary

Grant/Award: 19,150 shares

Grant/Award 1 txn

Insider Hoogerbrugge Jacqueline

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common shares, no par value	19,150	$0.00	$0.00

Holdings After Transaction: Common shares, no par value — 32,085 shares (Direct)

Footnotes (1)

1. F1. Represents 19,150 restricted shares granted to the reporting person on June 26, 2026. These restricted shares vest on the day prior to the Issuer's 2027 Annual General Meeting of Shareholders.

Key Figures

Restricted share grant: 19,150 shares Price per share: $0.00 per share Total holdings after grant: 32,085 shares +1 more

4 metrics

Restricted share grant 19,150 shares Equity award granted June 26, 2026

Price per share $0.00 per share Stated grant price for restricted shares

Total holdings after grant 32,085 shares Director’s direct ownership after transaction

Vesting condition Vests before 2027 AGM Restricted shares vest day prior to 2027 Annual General Meeting

Key Terms

restricted shares, Annual General Meeting of Shareholders, Grant, award, or other acquisition

3 terms

restricted shares financial

"Represents 19,150 restricted shares granted to the reporting person on June 26, 2026."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Annual General Meeting of Shareholders financial

"These restricted shares vest on the day prior to the Issuer's 2027 Annual General Meeting of Shareholders."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Orion S.A. (OEC) report for Jacqueline Hoogerbrugge?

Orion S.A. reported that director Jacqueline Hoogerbrugge received 19,150 restricted common shares as an equity grant. The shares were awarded at no cash cost per share and represent compensation rather than an open-market purchase or sale.

How many Orion S.A. (OEC) shares does Jacqueline Hoogerbrugge hold after this grant?

After the restricted share grant, Jacqueline Hoogerbrugge directly holds 32,085 Orion S.A. common shares. This total includes the newly granted 19,150 restricted shares, which are subject to vesting conditions tied to the company’s 2027 Annual General Meeting.

What are the vesting terms of the 19,150 restricted shares granted by Orion S.A. (OEC)?

The 19,150 restricted shares granted to Jacqueline Hoogerbrugge vest on the day prior to Orion S.A.'s 2027 Annual General Meeting. She must remain eligible through that date to fully earn the award, which aligns director compensation with ongoing board service.

Did Jacqueline Hoogerbrugge buy Orion S.A. (OEC) shares on the market in this Form 4?

No, the Form 4 shows a grant of 19,150 restricted shares as compensation, not an open-market purchase. The transaction code is “A,” indicating a grant or award acquisition at a stated price of zero per share rather than a cash investment.

Is the Orion S.A. (OEC) Form 4 transaction a sale of shares by Jacqueline Hoogerbrugge?

The reported transaction is not a sale; it is a grant of restricted shares. The filing shows an acquisition coded as a grant or award, with no shares disposed and no sale proceeds, increasing her overall direct share ownership in Orion S.A.

What does the transaction code "A" mean in the Orion S.A. (OEC) Form 4 filing?

The transaction code “A” in the Form 4 indicates a grant, award, or other acquisition of securities. In this case, it reflects that Jacqueline Hoogerbrugge received 19,150 restricted shares of Orion S.A. common stock as part of her director compensation package.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 05:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoogerbrugge Jacqueline

(Last) (First) (Middle)

C/O ORION S.A.

1700 CITY PLAZA DRIVE, SUITE 300

(Street)

SPRING TEXAS 77389

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orion S.A. [ OEC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares, no par value	06/26/2026		A		19,150	A	$0(1)	32,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 19,150 restricted shares granted to the reporting person on June 26, 2026. These restricted shares vest on the day prior to the Issuer's 2027 Annual General Meeting of Shareholders.

	/s/ Jacqueline Hoogerbrugge	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)